Recall of Quality Choice Cough Drops Creamy Strawberry
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. is recalling certain lots of QC Quality Choice Cough Drops Creamy Strawberry due to potential quality issues identified by the FDA.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on May 3, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
Which Products Are Affected
The affected product is QC Quality Choice, Pectin Oral Demulcent, Throat Soothing Drops, Creamy Strawberry Flavor, in 30-count bags. It is distributed by CDMA, Inc., Novi, MI 48375, and made in China. The product has NDC: 83698-625-30, UPC: 635515999398, Lot #: 20240720, and Expiration Date: 07/20/2026. The distribution is US Nationwide, and the quantity affected is N/A.
What You Should Do
Consumers should stop using the affected product and contact the recalling firm, Xiamen Kang Zhongyuan Biotechnology Co., Ltd., at their address: No. 2018, 2 Jietou Road, Xiamen, China, for instructions on returns or refunds, as the recall was initiated via letter.
Why This Matters
This recall underscores potential quality concerns in over-the-counter drugs, affecting consumers nationwide and highlighting the need for adherence to manufacturing standards.
Source
FDA Recall Number: D-0467-2026, attributed to the FDA.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,170 characters here).
Similar severity timing
Same severity (low) notices issued closest in time to May 3, 2026.
Frequently Asked Questions
Common questions about this FDA recall.